Churg-Strauss syndrome laboratory findings

Churg-Strauss syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Churg-Strauss syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Churg-Strauss syndrome laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Churg-Strauss syndrome laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Churg-Strauss syndrome laboratory findings
CDC on Churg-Strauss syndrome laboratory findings
Churg-Strauss syndrome laboratory findings in the news
Blogs on Churg-Strauss syndrome laboratory findings
Directions to Hospitals Treating Churg-Strauss syndrome
Risk calculators and risk factors for Churg-Strauss syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Laboratory Findings

Diagnostic markers include eosinophil granulocytes and granulomas in affected tissue and Anti-neutrophil cytoplasmic antibodies (ANCA) against neutrophil granulocytes.

The findings on other laboratory studies is nonspecific. Eosinophilia (5K-9K/uL) may be present. Anemia, elevated erythrocyte sedimentation rate (ESR), leukocytosis, elevated immunoglobin E (IgE), hypergammaglobulinemia, and a low-positive rheumatoid factor (RF